Matthew D. Hall
Orcid: 0000-0002-5073-442X
According to our database1,
Matthew D. Hall
authored at least 10 papers
between 2010 and 2022.
Collaborative distances:
Collaborative distances:
Timeline
Legend:
Book In proceedings Article PhD thesis Dataset OtherLinks
On csauthors.net:
Bibliography
2022
A Workflow of Integrated Resources to Catalyze Network Pharmacology Driven COVID-19 Research.
J. Chem. Inf. Model., 2022
Discovery of Small-Molecule VapC1 Nuclease Inhibitors by Virtual Screening and Scaffold Hopping from an Atomic Structure Revealing Protein-Protein Interactions with a Native VapB1 Inhibitor.
J. Chem. Inf. Model., 2022
Virtual Screening for the Discovery of Microbiome β-Glucuronidase Inhibitors to Alleviate Cancer Drug Toxicity.
J. Chem. Inf. Model., 2022
Minimal information for chemosensitivity assays (MICHA): a next-generation pipeline to enable the FAIRification of drug screening experiments.
Briefings Bioinform., 2022
2020
Proceedings of the Robotics: Science and Systems XVI, 2020
2019
J. Comput. Aided Mol. Des., 2019
Proceedings of the International Conference on Robotics and Automation, 2019
2016
<sup>18</sup>F-FCWAY, a serotonin 1A receptor radioligand, is a substrate for efflux transport at the human blood-brain barrier.
NeuroImage, 2016
2015
2010
[11C]N-desmethyl-loperamide, a substrate that selectively images P-glycoprotein function, is trapped in lysosomes.
NeuroImage, 2010